Flagship Pioneering's founder & CEO Noubar Afeyan discusses his firm's $3.6B fundraise today

blonca9
Jul 10, 2024
1 min read

Noubar Afeyan describes some areas that he sees the funding being deployed, his take on the current state of biotech, the IPO market, taking Flagship global, AI, and more.

Recent Posts

See All

As federal funding for cancer research has been jeopardized at NIH and academia, Parker Institute for Cancer Immunotherapy is one private institution ready to step up and broaden its impact

Mount Sinai has embraced AI as a drug discovery tool by launching this month its new AI Small Molecule Drug Discovery Center - Professor Avner Schlessinger tells us why

Jones Healthcare & Technology Innovation Conference: Jones Research analysts Soumit Roy and Justin Walsh share their take on biotech and comment on companies they cover

Flagship Pioneering's founder & CEO Noubar Afeyan discusses his firm's $3.6B fundraise today

Recent Posts

Join the BiotechTV mailing list

Follow BiotechTV

Sponsors

Sponsor Spotlight